vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and VERRA MOBILITY Corp (VRRM). Click either name above to swap in a different company.

VERRA MOBILITY Corp is the larger business by last-quarter revenue ($257.9M vs $196.0M, roughly 1.3× Axsome Therapeutics, Inc.). VERRA MOBILITY Corp runs the higher net margin — 7.3% vs -14.6%, a 21.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 16.4%). VERRA MOBILITY Corp produced more free cash flow last quarter ($5.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 10.9%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Verra Mobility Corp is a leading global smart mobility technology solution provider. It delivers toll management, parking and traffic compliance enforcement, connected vehicle services, and fleet management tools, serving government transport agencies, rental car operators, commercial fleet owners, and automotive partners across North America, Europe, and Asia-Pacific.

AXSM vs VRRM — Head-to-Head

Bigger by revenue
VRRM
VRRM
1.3× larger
VRRM
$257.9M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+48.6% gap
AXSM
65.0%
16.4%
VRRM
Higher net margin
VRRM
VRRM
21.9% more per $
VRRM
7.3%
-14.6%
AXSM
More free cash flow
VRRM
VRRM
$24.5M more FCF
VRRM
$5.7M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
10.9%
VRRM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AXSM
AXSM
VRRM
VRRM
Revenue
$196.0M
$257.9M
Net Profit
$-28.6M
$18.9M
Gross Margin
Operating Margin
-13.8%
16.7%
Net Margin
-14.6%
7.3%
Revenue YoY
65.0%
16.4%
Net Profit YoY
61.9%
128.3%
EPS (diluted)
$-0.55
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
VRRM
VRRM
Q4 25
$196.0M
$257.9M
Q3 25
$171.0M
$261.9M
Q2 25
$150.0M
$236.0M
Q1 25
$121.5M
$223.3M
Q4 24
$118.8M
$221.5M
Q3 24
$104.8M
$225.6M
Q2 24
$87.2M
$222.4M
Q1 24
$75.0M
$209.7M
Net Profit
AXSM
AXSM
VRRM
VRRM
Q4 25
$-28.6M
$18.9M
Q3 25
$-47.2M
$46.8M
Q2 25
$-48.0M
$38.6M
Q1 25
$-59.4M
$32.3M
Q4 24
$-74.9M
$-66.7M
Q3 24
$-64.6M
$34.7M
Q2 24
$-79.3M
$34.2M
Q1 24
$-68.4M
$29.1M
Operating Margin
AXSM
AXSM
VRRM
VRRM
Q4 25
-13.8%
16.7%
Q3 25
-27.0%
28.6%
Q2 25
-24.5%
26.8%
Q1 25
-46.9%
25.7%
Q4 24
-61.1%
-19.6%
Q3 24
-59.8%
28.3%
Q2 24
-89.5%
27.5%
Q1 24
-89.7%
25.9%
Net Margin
AXSM
AXSM
VRRM
VRRM
Q4 25
-14.6%
7.3%
Q3 25
-27.6%
17.9%
Q2 25
-32.0%
16.3%
Q1 25
-48.9%
14.5%
Q4 24
-63.1%
-30.1%
Q3 24
-61.7%
15.4%
Q2 24
-91.0%
15.4%
Q1 24
-91.1%
13.9%
EPS (diluted)
AXSM
AXSM
VRRM
VRRM
Q4 25
$-0.55
$0.12
Q3 25
$-0.94
$0.29
Q2 25
$-0.97
$0.24
Q1 25
$-1.22
$0.20
Q4 24
$-1.54
$-0.39
Q3 24
$-1.34
$0.21
Q2 24
$-1.67
$0.20
Q1 24
$-1.44
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
VRRM
VRRM
Cash + ST InvestmentsLiquidity on hand
$322.9M
$65.3M
Total DebtLower is stronger
$1.0B
Stockholders' EquityBook value
$88.3M
$293.0M
Total Assets
$689.8M
$1.6B
Debt / EquityLower = less leverage
3.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
VRRM
VRRM
Q4 25
$322.9M
$65.3M
Q3 25
$325.3M
$196.1M
Q2 25
$303.0M
$147.7M
Q1 25
$300.9M
$108.5M
Q4 24
$315.4M
$77.6M
Q3 24
$327.3M
$206.1M
Q2 24
$315.7M
$122.0M
Q1 24
$331.4M
$149.5M
Total Debt
AXSM
AXSM
VRRM
VRRM
Q4 25
$1.0B
Q3 25
$1.0B
Q2 25
$1.0B
Q1 25
$1.0B
Q4 24
$1.0B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$1.0B
Stockholders' Equity
AXSM
AXSM
VRRM
VRRM
Q4 25
$88.3M
$293.0M
Q3 25
$73.7M
$403.1M
Q2 25
$73.1M
$352.1M
Q1 25
$53.2M
$299.6M
Q4 24
$57.0M
$265.1M
Q3 24
$92.9M
$486.5M
Q2 24
$102.9M
$438.6M
Q1 24
$144.0M
$449.0M
Total Assets
AXSM
AXSM
VRRM
VRRM
Q4 25
$689.8M
$1.6B
Q3 25
$669.3M
$1.8B
Q2 25
$639.8M
$1.7B
Q1 25
$596.7M
$1.6B
Q4 24
$568.5M
$1.6B
Q3 24
$561.5M
$1.9B
Q2 24
$548.2M
$1.8B
Q1 24
$545.7M
$1.8B
Debt / Equity
AXSM
AXSM
VRRM
VRRM
Q4 25
3.51×
Q3 25
2.55×
Q2 25
2.93×
Q1 25
3.45×
Q4 24
3.90×
Q3 24
2.13×
Q2 24
2.36×
Q1 24
2.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
VRRM
VRRM
Operating Cash FlowLast quarter
$-18.7M
$40.0M
Free Cash FlowOCF − Capex
$-18.7M
$5.7M
FCF MarginFCF / Revenue
-9.6%
2.2%
Capex IntensityCapex / Revenue
0.0%
13.3%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$136.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
VRRM
VRRM
Q4 25
$-18.7M
$40.0M
Q3 25
$1.0M
$77.7M
Q2 25
$-32.4M
$75.1M
Q1 25
$-43.4M
$63.0M
Q4 24
$-26.2M
$40.5M
Q3 24
$-18.6M
$108.8M
Q2 24
$-30.1M
$40.0M
Q1 24
$-53.5M
$34.3M
Free Cash Flow
AXSM
AXSM
VRRM
VRRM
Q4 25
$-18.7M
$5.7M
Q3 25
$988.0K
$49.0M
Q2 25
$-32.4M
$40.3M
Q1 25
$-43.7M
$41.7M
Q4 24
$-26.2M
$21.6M
Q3 24
$-18.7M
$85.1M
Q2 24
$-30.2M
$26.0M
Q1 24
$-53.6M
$20.1M
FCF Margin
AXSM
AXSM
VRRM
VRRM
Q4 25
-9.6%
2.2%
Q3 25
0.6%
18.7%
Q2 25
-21.6%
17.1%
Q1 25
-36.0%
18.7%
Q4 24
-22.1%
9.8%
Q3 24
-17.9%
37.7%
Q2 24
-34.6%
11.7%
Q1 24
-71.4%
9.6%
Capex Intensity
AXSM
AXSM
VRRM
VRRM
Q4 25
0.0%
13.3%
Q3 25
0.0%
11.0%
Q2 25
0.0%
14.8%
Q1 25
0.3%
9.5%
Q4 24
0.0%
8.5%
Q3 24
0.1%
10.5%
Q2 24
0.1%
6.3%
Q1 24
0.1%
6.8%
Cash Conversion
AXSM
AXSM
VRRM
VRRM
Q4 25
2.12×
Q3 25
1.66×
Q2 25
1.95×
Q1 25
1.95×
Q4 24
Q3 24
3.13×
Q2 24
1.17×
Q1 24
1.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

VRRM
VRRM

Services$239.5M93%
CA$8.4M3%
GB$5.7M2%
Other Customer$1.6M1%
Parking Solutions$1.1M0%

Related Comparisons